PMID: 11918538Mar 29, 2002Paper

Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma

British Journal of Haematology
M ZeisL Uharek

Abstract

Idiotype (Id) vaccination provides an innovative treatment modality against B-cell malignancies. In multiple myeloma patients, however, the antitumoral potential of this immunotherapeutic concept is limited. In an attempt to improve the therapeutic effectiveness of Id vaccination, we added Flt3 ligand (Flt3-L) and interleukin 2 (IL-2) to the protocol. Balb/c mice were inoculated i.p. (d -2) with different doses (1-5 x 10(5)) of HOPC myeloma cells, secreting the IgHOPC Id-protein. Two days later, animals were treated with Flt3-L (10 microg per mouse/d, given i.p) for 10 consecutive days (d 0-9). On d 5 and d 11, myeloma-specific immunoglobulin (Ig(HOPC)) was administered s.c., together with incomplete Freund adjuvans (IFA) followed by the administration of IL-2 (2 x 10.000/d given i.p) for 10 d (d 5-14). Whereas Ig(HOPC), Flt3-L or IL-2, given alone, did not elicit long-term survival, the combination of IL-2 or Flt3-L with Id vaccination achieved a complete tumour rejection in 27% and 41% of mice respectively. However, the most powerful antimyeloma effects were induced by Flt3-L + Id vaccination + IL-2: 81% of the treated animals experienced long-term survival (> 180 d). Both natural killer (NK) cells and CD8+ T cells may be inv...Continue Reading

References

Dec 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·S Sirisinha, H N Eisen
Jun 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·R G LynchH N Eisen
Nov 1, 1995·European Journal of Immunology·B BogenG F Lauritzsen
Mar 1, 1994·European Journal of Immunology·V FlamandM Moser
Jun 5, 1997·The New England Journal of Medicine·R Bataille, J L Harousseau
Nov 14, 1997·Molecular Medicine Today·A Bianchi, M Massaia
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·K ShimizuJ J Mulé
Mar 12, 1999·Annual Review of Medicine·J M Timmerman, R Levy
Apr 1, 1999·Biotechnology and Bioengineering·E P MeloJ M Cabral
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M Timmerman, R Levy

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.